Envoy Medical, Inc. (COCH) Earnings History
Net Loss5 years of earnings data (2021–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Envoy Medical, Inc. (COCH) Earnings Overview
As of June 30, 2026, Envoy Medical, Inc. (COCH) reported trailing twelve-month net income of -$23M, reflecting +17.4% year-over-year growth. The company earned $-0.34 per diluted share over the past four quarters, with a net profit margin of -9857.3%.
Looking at the long-term picture, COCH's historical earnings data spans multiple years. The company achieved its highest annual net income of -$9M in fiscal 2021.
Envoy Medical, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including LNTH ($279M net income, 15.2% margin), MDT ($4.80B net income, 13.2% margin), ABT ($6.28B net income, 14.7% margin), COCH has room to improve margins relative to the peer group. Compare COCH vs LNTH →
COCH Earnings vs Peers
Earnings metrics vs comparable public companies
COCH Historical Earnings Data (2021–2025)
5 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$24M | -14.2% | -$22M | $-1.23 | -9857.3% | -9240.7% |
| 2024 | -$21M | +30.5% | -$19M | $-1.49 | -9242.2% | -8558.2% |
| 2023 | -$30M | -87.9% | -$18M | $-2.54 | -9469.0% | -5809.8% |
| 2022 | -$16M | -83.6% | -$9M | $-1.57 | -6718.6% | -3673.4% |
| 2021 | -$9M | - | -$7M | $-1.05 | -2798.4% | -2216.5% |
Download Data
Export COCH earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
5+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
COCH — Frequently Asked Questions
Quick answers to the most common questions about buying COCH stock.
What is COCH earnings per share (EPS)?
COCH trailing twelve-month (TTM) diluted EPS is $-0.34, reflecting +17.4% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2021 to 2025 is available in the table on this page.
What is Envoy Medical, Inc.'s net income?
Envoy Medical, Inc. (COCH) trailing twelve-month net income is $-23M as of 2025. Earnings grew +17.4% year-over-year.
Is COCH profitable?
COCH is not currently profitable on a TTM basis, reporting a net loss of $-23M. Net margin is -9857.3%. Investors should monitor for a return to profitability.
What is COCH's earnings growth rate?
COCH compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2021 to 2025.
What are COCH's profit margins?
Envoy Medical, Inc. net profit margin is -9857.3%, operating margin is -9240.7%, and gross margin is -262.7%. Below-average margins reflect competitive or cost pressures. Return on Equity is N/A.
Is COCH growing earnings?
Yes, COCH earnings are accelerating — EPS growth of +17.4% exceeds the 5-year CAGR of N/A. TTM net income reached $-23M. Earnings momentum is strengthening.
What was COCH's best earnings year?
Envoy Medical, Inc.'s highest annual net income on record is $-9M, achieved in fiscal year 2021. Earnings history on this page spans 2021 to 2025 and includes all annual and quarterly figures.
What were COCH's earnings last quarter?
COCH's most recent reported quarter was Q1 2026. Net income was $-4M with diluted EPS of $-0.08. For a full breakdown of all quarters, see the quarterly earnings table on this page.